What one share of Agios Pharmaceuticals holds
We are a commercial-stage biopharmaceutical company dedicated to redefining the future of rare disease treatment. Fueled by connections, we build trusted partnerships with communities, collaborating to develop and deliver innovative medicines with the potential to transform lives.
Agios Pharmaceuticals’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Sales | $1.68 |
|---|---|
| Profit | −$7.01 |
| Capex (buildings and equipment) | $0.08 |
| Free cash flow | −$6.22 |
| Cash and investments | $1.67 |
| Book value | $17.21 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2011 | $7.25 | −$8.90 | $0.63 | −$5.68 | — | −$17.52 |
| 2012 | $7.38 | −$8.02 | $0.43 | −$15.00 | — | −$19.92 |
| 2013 | $1.66 | −$2.83 | $0.08 | −$3.74 | — | — |
| 2014 | $1.94 | −$1.59 | $0.07 | −$1.83 | — | $11.44 |
| 2015 | $1.58 | −$3.15 | $0.54 | −$2.59 | — | $9.16 |
| 2016 | $1.79 | −$5.07 | $0.25 | $0.73 | — | $8.49 |
| 2017 | $0.92 | −$6.75 | $0.10 | −$6.22 | — | $7.69 |
| 2018 | $1.64 | −$6.03 | $0.12 | −$5.42 | — | $11.81 |
| 2019 | $1.97 | −$6.86 | $0.20 | −$6.38 | — | $9.36 |
| 2020 | $0.00 | −$4.74 | $0.20 | −$4.42 | — | $5.77 |
| 2021 | $0.00 | $26.55 | $0.10 | −$6.83 | — | $23.78 |
| 2022 | $0.26 | −$4.23 | $0.09 | −$5.74 | — | $20.00 |
| 2023 | $0.48 | −$6.33 | $0.02 | −$5.34 | — | $14.50 |
| 2024 | $0.63 | $11.64 | $0.03 | −$6.76 | — | $26.96 |
| 2025 | $0.93 | −$7.12 | $0.07 | −$6.51 | — | $20.41 |
Common questions about Agios Pharmaceuticals
How much does one share of Agios Pharmaceuticals earn?
Over the last 12 months, Agios Pharmaceuticals lost $7.01 for each share on $1.68 of sales.
Does Agios Pharmaceuticals pay a dividend?
Agios Pharmaceuticals didn’t pay a dividend over the last 12 months, according to its SEC filings.
What is Agios Pharmaceuticals’s book value per share?
Agios Pharmaceuticals’s book value is $17.21 per share: what would be left for each share if it sold everything at the values on its books and paid every debt, as of June 30, 2026.
How much cash and debt does each share of Agios Pharmaceuticals have?
Each share of Agios Pharmaceuticals has $1.67 of cash and investments, as of June 30, 2026.
What is Agios Pharmaceuticals’s free cash flow per share?
−$6.22 per share over the last 12 months. Free cash flow is the cash left over after spending on buildings and equipment.
Has Agios Pharmaceuticals bought back shares?
Agios Pharmaceuticals’s share count rose about 1824% from 2011 to 2025. That dilution means each share owns a smaller slice of the company.
From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.